Based on these observations, we propose that when Trousseau's syndrome develops in lung cancer patients, continuous heparin should be administered, and genetic testing and PD-L1 staining should be performed to guide appropriate treatment as soon as possible. The gene discussed is CD274; the disease is lung carcinoma.